167 related articles for article (PubMed ID: 30696657)
21. Interleukin-6: a villain in the drama of pancreatic cancer development and progression.
Holmer R; Goumas FA; Waetzig GH; Rose-John S; Kalthoff H
Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):371-80. PubMed ID: 25100121
[TBL] [Abstract][Full Text] [Related]
22. CXCL17 and ICAM2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis.
Hiraoka N; Yamazaki-Itoh R; Ino Y; Mizuguchi Y; Yamada T; Hirohashi S; Kanai Y
Gastroenterology; 2011 Jan; 140(1):310-21. PubMed ID: 20955708
[TBL] [Abstract][Full Text] [Related]
23. Pomalidomide for the management of refractory multiple myeloma.
Summers BB; Cole SW; Olin JL
Am J Health Syst Pharm; 2014 Sep; 71(17):1443-8. PubMed ID: 25147167
[TBL] [Abstract][Full Text] [Related]
24. Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity.
Padoan A; Plebani M; Basso D
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30764482
[TBL] [Abstract][Full Text] [Related]
25. Induction of M2-macrophages by tumour cells and tumour growth promotion by M2-macrophages: a quid pro quo in pancreatic cancer.
Partecke LI; Günther C; Hagemann S; Jacobi C; Merkel M; Sendler M; van Rooijen N; Käding A; Nguyen Trung D; Lorenz E; Diedrich S; Weiss FU; Heidecke CD; von Bernstorff W
Pancreatology; 2013; 13(5):508-16. PubMed ID: 24075516
[TBL] [Abstract][Full Text] [Related]
26. Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice.
Smith JP; Wang S; Nadella S; Jablonski SA; Weiner LM
Cancer Immunol Immunother; 2018 Feb; 67(2):195-207. PubMed ID: 29043413
[TBL] [Abstract][Full Text] [Related]
27. The Pivotal Role of Macrophages in the Pathogenesis of Pancreatic Diseases.
Ryu S; Lee EK
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891952
[TBL] [Abstract][Full Text] [Related]
28. Preconditioning of bone marrow-derived mesenchymal stem cells highly strengthens their potential to promote IL-6-dependent M2b polarization.
Philipp D; Suhr L; Wahlers T; Choi YH; Paunel-Görgülü A
Stem Cell Res Ther; 2018 Oct; 9(1):286. PubMed ID: 30359316
[TBL] [Abstract][Full Text] [Related]
29. CD14/TLR4 priming potentially recalibrates and exerts anti-tumor efficacy in tumor associated macrophages in a mouse model of pancreatic carcinoma.
Prakash H; Nadella V; Singh S; Schmitz-Winnenthal H
Sci Rep; 2016 Aug; 6():31490. PubMed ID: 27511884
[TBL] [Abstract][Full Text] [Related]
30. Pomalidomide is effective for prevention and treatment of experimental skin fibrosis.
Weingärtner S; Zerr P; Tomcik M; Palumbo-Zerr K; Distler A; Dees C; Beyer C; Shankar SL; Cedzik D; Schafer PH; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2012 Nov; 71(11):1895-9. PubMed ID: 22904257
[TBL] [Abstract][Full Text] [Related]
31. Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment.
Gomez-Chou SB; Swidnicka-Siergiejko AK; Badi N; Chavez-Tomar M; Lesinski GB; Bekaii-Saab T; Farren MR; Mace TA; Schmidt C; Liu Y; Deng D; Hwang RF; Zhou L; Moore T; Chatterjee D; Wang H; Leng X; Arlinghaus RB; Logsdon CD; Cruz-Monserrate Z
Cancer Res; 2017 May; 77(10):2647-2660. PubMed ID: 28249896
[TBL] [Abstract][Full Text] [Related]
32. The immune microenvironment in vulvar (pre)cancer: review of literature and implications for immunotherapy.
Abdulrahman Z; Kortekaas KE; De Vos Van Steenwijk PJ; Van Der Burg SH; Van Poelgeest MI
Expert Opin Biol Ther; 2018 Dec; 18(12):1223-1233. PubMed ID: 30373410
[TBL] [Abstract][Full Text] [Related]
33. Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression.
Kaneda MM; Cappello P; Nguyen AV; Ralainirina N; Hardamon CR; Foubert P; Schmid MC; Sun P; Mose E; Bouvet M; Lowy AM; Valasek MA; Sasik R; Novelli F; Hirsch E; Varner JA
Cancer Discov; 2016 Aug; 6(8):870-85. PubMed ID: 27179037
[TBL] [Abstract][Full Text] [Related]
34. Rate of CRL4(CRBN) substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4.
Bjorklund CC; Lu L; Kang J; Hagner PR; Havens CG; Amatangelo M; Wang M; Ren Y; Couto S; Breider M; Ning Y; Gandhi AK; Daniel TO; Chopra R; Klippel A; Thakurta AG
Blood Cancer J; 2015 Oct; 5(10):e354. PubMed ID: 26430725
[TBL] [Abstract][Full Text] [Related]
35. Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules.
Bolzoni M; Storti P; Bonomini S; Todoerti K; Guasco D; Toscani D; Agnelli L; Neri A; Rizzoli V; Giuliani N
Exp Hematol; 2013 Apr; 41(4):387-97.e1. PubMed ID: 23178378
[TBL] [Abstract][Full Text] [Related]
36. Acceleration of pancreatic tumorigenesis under immunosuppressive microenvironment induced by Reg3g overexpression.
Liu X; Zhou Z; Cheng Q; Wang H; Cao H; Xu Q; Tuo Y; Jiang L; Zou Y; Ren H; Xiang M
Cell Death Dis; 2017 Sep; 8(9):e3033. PubMed ID: 28880262
[TBL] [Abstract][Full Text] [Related]
37. The role of inflammatory cytokines and tumor associated macrophages (TAMs) in microenvironment of pancreatic cancer.
Farajzadeh Valilou S; Keshavarz-Fathi M; Silvestris N; Argentiero A; Rezaei N
Cytokine Growth Factor Rev; 2018 Feb; 39():46-61. PubMed ID: 29373197
[TBL] [Abstract][Full Text] [Related]
38. The pentacyclic triterpene Lupeol switches M1 macrophages to M2 and ameliorates experimental inflammatory bowel disease.
Zhu Y; Li X; Chen J; Chen T; Shi Z; Lei M; Zhang Y; Bai P; Li Y; Fei X
Int Immunopharmacol; 2016 Jan; 30():74-84. PubMed ID: 26655877
[TBL] [Abstract][Full Text] [Related]
39. M1-/M2-macrophages contribute to the development of GST-P-positive preneoplastic lesions in chemically-induced rat cirrhosis.
Wijesundera KK; Izawa T; Tennakoon AH; Golbar HM; Tanaka M; Kuwamura M; Yamate J
Exp Toxicol Pathol; 2015 Sep; 67(9):467-75. PubMed ID: 26205097
[TBL] [Abstract][Full Text] [Related]
40. Anti-PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment.
Xiong H; Mittman S; Rodriguez R; Moskalenko M; Pacheco-Sanchez P; Yang Y; Nickles D; Cubas R
Cancer Res; 2019 Apr; 79(7):1493-1506. PubMed ID: 30679180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
